Margrave David R. bought LTRN
October 29, 2021 · Form 4 insider transaction
Margrave David R. bought 26,100 shares of Lantern Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1425 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,100
Price
$0.00
Total value
N/A
InsiderMargrave David R.
Role—
CompanyLantern Pharma Inc. (LTRN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 29, 2021
Filing dateSeptember 23, 2025
Shares owned after26,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 29, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing November 29, 2021.